文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

多巴酚丁胺与血管加压素对脓毒症大鼠肝脏和结肠微循环及线粒体功能的影响:一项随机安慰剂对照试验

Effects of Dobutamine and Vasopressin on Microcirculation and Mitochondrial Function in the Liver and Colon of Septic Rats: A Randomized Placebo-Controlled Trial.
PubMed 文献 · Shock · 2025-11-25
一句话结论脓毒症大鼠中,多巴酚丁胺改善结肠微循环氧合和血流,但联用血管加压素削弱其氧合效应;肝脏微循环和线粒体呼吸基本无变化。

该研究在盲肠升结肠支架腹膜炎或假手术24小时后,将88只雄性Wistar大鼠随机分为溶媒、血管加压素、多巴酚丁胺及两药联用组,在脓毒症或假手术条件下观察。用组织反射光谱法和激光多普勒血流仪测量结肠和肝脏微循环氧合(µHbO2)及微血管血流(µFlow)90分钟,并用高分辨率呼吸测定法评估脓毒症动物结肠和肝脏匀浆的线粒体呼吸。结果显示,脓毒症大鼠中多巴酚丁胺显著改善结肠微血管氧合(∆µHbO2 10.2%±13.4% vs 对照组-2.3%±4.4%,P<0.05)和微血管血流(∆µFlow 30±20任意单位 vs 基线,P<0.05);多巴酚丁胺联合血管加压素增加微血管血流(∆µFlow 28±27任意单位 vs 基线,P<0.05)但未改善组织氧合。肝脏微循环和线粒体呼吸基本无变化。

要点

  • 脓毒症大鼠中,多巴酚丁胺使结肠微血管氧合变化∆µHbO2达10.2%±13.4%,对照组为-2.3%±4.4%(P<0.05)。
  • 多巴酚丁胺使结肠微血管血流变化∆µFlow达30±20任意单位(vs 基线,P<0.05)。
  • 多巴酚丁胺联合血管加压素使结肠∆µFlow达28±27任意单位(vs 基线,P<0.05),但未改善组织氧合。
  • 肝脏微循环和线粒体呼吸在多巴酚丁胺或血管加压素干预后基本无变化。
  • 作者结论:多巴酚丁胺改善脓毒症结肠微循环,同时给予血管加压素削弱其氧合效应。

适用人群与场景

  • 盲肠升结肠支架腹膜炎或假手术24小时后的雄性Wistar大鼠,共88只。

处置流程与药物剂量

  • 脓毒症或假手术大鼠随机接受溶媒、血管加压素、多巴酚丁胺或两药联用。
  • 干预后测量结肠和肝脏微循环氧合(µHbO2)及微血管血流(µFlow)90分钟。
  • 对脓毒症动物结肠和肝脏匀浆用高分辨率呼吸测定法评估线粒体呼吸。

研究设计与关键结果

  • 随机安慰剂对照动物实验,88只雄性Wistar大鼠,比较溶媒、血管加压素、多巴酚丁胺及联用在脓毒症或假手术条件下的效应。
  • 脓毒症大鼠中,多巴酚丁胺显著改善结肠微血管氧合(∆µHbO2 10.2%±13.4% vs 对照组-2.3%±4.4%及vs基线,P<0.05)。
  • 多巴酚丁胺使结肠微血管血流增加(∆µFlow 30±20任意单位 vs 基线,P<0.05)。
  • 多巴酚丁胺联合血管加压素使结肠微血管血流增加(∆µFlow 28±27任意单位 vs 基线,P<0.05),但未改善组织氧合。
  • 肝脏微循环和线粒体呼吸基本无变化。

证据类型、等级与局限

  • 随机安慰剂对照动物实验,原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:多巴酚丁胺改善脓毒症结肠微循环,而同时给予血管加压素削弱其氧合效应。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is characterized by systemic inflammation and microcirculatory dysfunction, contributing to multiorgan failure. In the gastrointestinal tract, impaired microcirculation and mitochondrial dysfunction promote barrier failure and bacterial translocation. While dobutamine is commonly used to augment cardiac output in septic shock, its direct effects on intestinal microcirculation and mitochondrial respiration remain unclear. The microcirculatory impact of adjunctive low-dose vasopressin is similarly uncertain.

METHODS: Twenty-four hours after colon ascendens stent peritonitis or sham surgery, 88 male Wistar rats were randomized to receive vehicle, vasopressin, dobutamine, or their combination under septic or sham conditions. Colonic and hepatic microcirculatory oxygenation (µHbO 2 ) and microvascular blood flow (µFlow) were measured for 90 minutes using tissue-reflectance spectrophotometry and laser Doppler flowmetry. Mitochondrial respiration was assessed in colon and liver homogenates of septic animals by high-resolution respirometry. Microcirculatory data were analyzed using mixed-effects models with Tukey's and Dunnett's post hoc tests. Mitochondrial data were analyzed using the Kruskal-Wallis test. A two-sided P < 0.05 was considered statistically significant.

RESULTS: In septic rats, dobutamine significantly improved colonic microvascular oxygenation (∆µHbO 2 10.2% ± 13.4% vs. -2.3% ± 4.4% in controls and vs. baseline, P < 0.05) and microvascular blood flow (∆µFlow 30 ± 20 arbitrary units vs. baseline, P < 0.05). Combined dobutamine and vasopressin increased microvascular blood flow (∆µFlow 28 ± 27 arbitrary units vs. baseline, P < 0.05) but did not improve tissue oxygenation. Hepatic microcirculation and mitochondrial respiration remained largely unaltered.

CONCLUSIONS: Dobutamine improves colonic microcirculation in sepsis, whereas concomitant vasopressin attenuates its oxygenation effects.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Marcus C, Hof S, Thelen P, et al. Effects of Dobutamine and Vasopressin on Microcirculation and Mitochondrial Function in the Liver and Colon of Septic Rats: A Randomized Placebo-Controlled Trial. Shock. 2025. PMID: 41670978. doi:10.1097/SHK.0000000000002765

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。